Current practice and access to prostate ...
Document type :
Article dans une revue scientifique: Article original
Title :
Current practice and access to prostate MR imaging in France
Author(s) :
Renard-Penna, Raphaele [Auteur correspondant]
Institut Universitaire de Cancérologie [Sorbonne Université] [IUC]
Rouvière, O. [Auteur]
Université Claude Bernard Lyon 1 [UCBL]
Puech, Pascal [Auteur]
Thérapies Assistées par Lasers et Immunothérapies pour l'Oncologie - U 1189 [OncoThAI]
Borgogno, Claude [Auteur]
Service d'urologie [CH René Dubos Pontoise]
Abbas, L. [Auteur]
Epidémiologie, Systèmes d'Information, Modélisation
CHU Pitié-Salpêtrière [AP-HP]
Roy, C. [Auteur]
Service de radiologie [Strasbourg]
Claudon, Michel [Auteur]
Département de Radiologie adultes [CHRU Nancy]
Correas, J.-M. [Auteur]
Cormier, Luc [Auteur]
UFR des Sciences de Santé (Université de Bourgogne)
Ploussard, G. [Auteur]
Service d'Urologie [CHU Saint-Louis]
Mejean, A. [Auteur]
Hôpital Européen Georges Pompidou [APHP] [HEGP]
Tezenas-Du-Montcel, S. [Auteur]
CHU Pitié-Salpêtrière [AP-HP]
Epidémiologie, Systèmes d'Information, Modélisation
Rozet, F. [Auteur]
Service d'urologie [Institut Mutualiste Montsouris]
Institut Universitaire de Cancérologie [Sorbonne Université] [IUC]
Rouvière, O. [Auteur]
Université Claude Bernard Lyon 1 [UCBL]
Puech, Pascal [Auteur]
Thérapies Assistées par Lasers et Immunothérapies pour l'Oncologie - U 1189 [OncoThAI]
Borgogno, Claude [Auteur]
Service d'urologie [CH René Dubos Pontoise]
Abbas, L. [Auteur]
Epidémiologie, Systèmes d'Information, Modélisation
CHU Pitié-Salpêtrière [AP-HP]
Roy, C. [Auteur]
Service de radiologie [Strasbourg]
Claudon, Michel [Auteur]
Département de Radiologie adultes [CHRU Nancy]
Correas, J.-M. [Auteur]
Cormier, Luc [Auteur]
UFR des Sciences de Santé (Université de Bourgogne)
Ploussard, G. [Auteur]
Service d'Urologie [CHU Saint-Louis]
Mejean, A. [Auteur]
Hôpital Européen Georges Pompidou [APHP] [HEGP]
Tezenas-Du-Montcel, S. [Auteur]
CHU Pitié-Salpêtrière [AP-HP]
Epidémiologie, Systèmes d'Information, Modélisation
Rozet, F. [Auteur]
Service d'urologie [Institut Mutualiste Montsouris]
Journal title :
Diagnostic and interventional imaging
Pages :
1125 - 1129
Publisher :
Elsevier
Publication date :
2016-11
ISSN :
2211-5684
English keyword(s) :
Prostate cancer
Magnetic resonance imaging
Recommendations
active surveillance
cancer diagnosis
scoring system
biopsy
men
validation
volume
Magnetic resonance imaging
Recommendations
active surveillance
cancer diagnosis
scoring system
biopsy
men
validation
volume
HAL domain(s) :
Sciences du Vivant [q-bio]/Ingénierie biomédicale/Imagerie
English abstract : [en]
Purpose: To obtain an overview of the degree of discrepancy between current clinical practice of prostate magnetic resonance imaging (MRI) in France and recommendations.Materials and methods: A brief survey was sent to ...
Show more >Purpose: To obtain an overview of the degree of discrepancy between current clinical practice of prostate magnetic resonance imaging (MRI) in France and recommendations.Materials and methods: A brief survey was sent to 1229 members of the French society of urology in order to identify their indications of prostate MRI and its impact on patient management. The urologists were asked to answer several questions regarding age, practice modality, prostate MRI examinations (technique, indication before first biopsy, second biopsy, cancer staging, active surveillance, recurrence, focal therapy) and quality of reports.Results: A total of 445 responses were received (participation rate of 36%). The mean delay for obtaining an appointment for prostate MRI ranged between 1530 days in 54%. Fifty-four percent of MRI reports contained a PIRADS score and 23% a Likert score. The indications of multiparametric-MRI were tumor detection/location prior to repeat biopsy (90%), cancer staging (85%), management of patients under active surveillance (85%), selection of candidates to focal therapy (63%), tumor detection/location in biopsy naive patients (53%), detection of local recurrence after radical (51%). Only 119 urologists (28.6%) had access to image fusion (MRI and transrectal ultrasound) and 351 (85.4%) used cognitive fusion. Mostly, targeted biopsies are done by urologists alone (nearly 80%), a very few are done by radiologists (8%) or by the two of them in collaboration (12%).Conclusion: The majority of urologists consider that prostate MRI is essential for the management of patients with prostate cancer. Practices are ahead of recommendations particularly before the first biopsy and in active surveillance.Show less >
Show more >Purpose: To obtain an overview of the degree of discrepancy between current clinical practice of prostate magnetic resonance imaging (MRI) in France and recommendations.Materials and methods: A brief survey was sent to 1229 members of the French society of urology in order to identify their indications of prostate MRI and its impact on patient management. The urologists were asked to answer several questions regarding age, practice modality, prostate MRI examinations (technique, indication before first biopsy, second biopsy, cancer staging, active surveillance, recurrence, focal therapy) and quality of reports.Results: A total of 445 responses were received (participation rate of 36%). The mean delay for obtaining an appointment for prostate MRI ranged between 1530 days in 54%. Fifty-four percent of MRI reports contained a PIRADS score and 23% a Likert score. The indications of multiparametric-MRI were tumor detection/location prior to repeat biopsy (90%), cancer staging (85%), management of patients under active surveillance (85%), selection of candidates to focal therapy (63%), tumor detection/location in biopsy naive patients (53%), detection of local recurrence after radical (51%). Only 119 urologists (28.6%) had access to image fusion (MRI and transrectal ultrasound) and 351 (85.4%) used cognitive fusion. Mostly, targeted biopsies are done by urologists alone (nearly 80%), a very few are done by radiologists (8%) or by the two of them in collaboration (12%).Conclusion: The majority of urologists consider that prostate MRI is essential for the management of patients with prostate cancer. Practices are ahead of recommendations particularly before the first biopsy and in active surveillance.Show less >
Language :
Anglais
Peer reviewed article :
Oui
Audience :
Internationale
Popular science :
Non
Source :
Files
- https://doi.org/10.1016/j.diii.2016.06.010
- Open access
- Access the document
- https://doi.org/10.1016/j.diii.2016.06.010
- Open access
- Access the document
- https://doi.org/10.1016/j.diii.2016.06.010
- Open access
- Access the document
- https://doi.org/10.1016/j.diii.2016.06.010
- Open access
- Access the document
- https://doi.org/10.1016/j.diii.2016.06.010
- Open access
- Access the document
- https://doi.org/10.1016/j.diii.2016.06.010
- Open access
- Access the document
- https://doi.org/10.1016/j.diii.2016.06.010
- Open access
- Access the document
- https://doi.org/10.1016/j.diii.2016.06.010
- Open access
- Access the document
- j.diii.2016.06.010
- Open access
- Access the document